Ginkgolide B Treatment Of Atherosclerotic Cerebral Infarction In Clinical Studies

Objective: To injection Ginkgolide B injection in the treatment of atherosclerosis cerebral infarction (ischemic stroke recovery - bleeding resistance Tongxinluo card) clinical efficacy and safety of evaluation.Methods: This study used randomized, blind, parallel positive drug control, multi-center clinical trial approach. Selected cases of 60 cases, the EOC is divided into a test group, the control group. Administration: a test group, Ginkgolide B injection 40 mg, adding 0.9 percent sodium chloride injection 250 ml, intravenous drip, day 1; the control group, Ginaton 20 ml, adding 0.9 percent sodium chloride injection 250 ml, intravenous drip, day 1. Each group 14 days of continuous use.Results: Ginkgolide B injection to reduce neurological deficit, improve the TCM Syndrome has a good effect. Safe and reliable. And imported drugs Ginaton considerable effect.Conclusion: Ginkgolide B injection can significantly improve stroke patients with clinical symptoms, no significant side effects and adverse reactions, the treatment of atherosclerosis cerebral infarction safe and effective.